Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.
Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M. Shabsigh R, et al. Among authors: eardley i. Int J Clin Pract. 2008 May;62(5):791-8. doi: 10.1111/j.1742-1241.2008.01696.x. Epub 2008 Feb 2. Int J Clin Pract. 2008. PMID: 18266714 Free PMC article. Review.
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).
Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, Cuzin B, Moncada I, Martin-Morales A, Yassin A, Meuleman E, Eardley I, Dean JD, Shabsigh R. Buvat J, et al. Among authors: eardley i. J Sex Med. 2011 Jan;8(1):284-93. doi: 10.1111/j.1743-6109.2010.01956.x. J Sex Med. 2011. PMID: 20704642 Clinical Trial.
Pharmacotherapy for erectile dysfunction.
Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, Munarriz R, Lee SW. Eardley I, et al. J Sex Med. 2010 Jan;7(1 Pt 2):524-40. doi: 10.1111/j.1743-6109.2009.01627.x. J Sex Med. 2010. PMID: 20092451 Review.
185 results